VitaNova Life Sciences Corporation (VNOV)
OTCMKTS · Delayed Price · Currency is USD
2.380
0.00 (0.00%)
Oct 8, 2026, 4:00 PM EDT
VitaNova Life Sciences Revenue
VitaNova Life Sciences had revenue of $321.58K in the quarter ending July 31, 2026, with 209.51% growth. This brings the company's revenue in the last twelve months to $3.24M, up 22.04% year-over-year. In the fiscal year ending April 30, 2026, VitaNova Life Sciences had annual revenue of $3.03M with 13.65% growth. That makes VitaNova Life Sciences the 41,224th largest company in the world by revenue and 5,543rd in the United States.
Revenue (ttm)
3.24M
Revenue Growth
+22.04%
P/S Ratio
6.12
Revenue / Employee
463.32K
Employees
7
Market Cap
19.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 3.03M | 363.43K | 13.65% |
| Apr 30, 2025 | 2.66M | 2.09M | 366.47% |
| Apr 30, 2024 | 570.69K | 532.69K | 1,401.83% |
| Apr 30, 2023 | 38.00K | -82.00K | -68.33% |
| Apr 30, 2022 | 120.00K | - | - |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Medicine | 65.76M |
| Synergy CHC | 27.70M |
| PD-Rx Pharmaceuticals | 18.35M |
| Exlites Holdings International | 9.42M |
| Pharmagen | 4.41M |
| Gold Enterprise Group | 559.55K |
| Global Medical Products Holdings | 45.96K |
| DH Enchantment | -42.87K |